Dr. Sharman's CLL & Lymphoma Blog

Translating basic science and clinical breakthroughs into language we all can understand

Pages

  • Home
  • CLL Topics
  • NHL Topics
  • Research
  • CLL / NHL Doctors
  • WVCI Open Studies

NHL Topics

The following are posts I have written on NHL all categorized for easy access.  Hopefully this is a good way to familiarize yourself with the different things I think you should know.


Lymphoma overview topics
Understanding how the many types of NHL relate to each other and what makes them different
Indolent Lymphoma (follicular, marginal zone, small lymphocytic, marginal zone)
Lymphoma Grade and Stage
Transformation

Lymphoma Biology
How did I get NHL / CLL
 Molecular Prognosis in DLBCL
Tumor Lysis Syndrome


Clinical Management
CT and PET scans
How I treat follicular lymphoma (part 1)
How I treat follicular lymphoma (part 2)
How I treat Diffuse Large B Cell Lymphoma
What is R-CHOP Chemotherapy
Personalized therapy for DLBCL based upon ABC or GCB subtype
Relapsed DLBCL
Nutritional Supplements
Watch and Wait
Finding a clinical trial
Stem Cell Transplant
Monoclonal B Cell Lymphocytosis (MBL)
Off label drug use
Rituximab therapy in indolent NHL
Immunotherapy - how the past informs the future

Other
Dying
Telling your story
Home
View mobile version
Subscribe to: Posts (Atom)
Twitter @Jeff_Sharman

Willamette Valley Cancer

Willamette Valley Cancer
I am a hematologist oncologist practicing at the Willamette Valley Cancer Institute in Eugene Oregon. I am also the medical director of hematology research for US Oncology a community based research network with sites throughout the United States.

The purpose of this blog is to serve as a resource for the patients I see every day. In our visits, I often find I want to give a more comprehensive discussion than what time allows. I hope this blog allows my patients to feel more informed about what we are doing and why we are recommending it.

This blog is NOT a substitute for medical advice from your own doctor and should not be interpreted as an individual therapeutic recommendation

Total Pageviews

Search This Blog

Translate

Posts By Topic

  • 11q (2)
  • 13q (3)
  • 17p (7)
  • Antibody Drug Conjugate (2)
  • atm (2)
  • b cell lymphocytosis (1)
  • BCL-2 (2)
  • BCR Signal Inhibitor (8)
  • bendamustine (2)
  • birc3 (2)
  • Brentuximab (3)
  • BTK (8)
  • CAL-101 / GS-1101 (5)
  • CAR T-cells (3)
  • cd20 (5)
  • clinical trials (1)
  • CLL biology (15)
  • cll prognosis (4)
  • CLL treatment (15)
  • clonal evolution (3)
  • cure (1)
  • diffuse large B cell lymphoma (9)
  • drug costs (9)
  • drug prices (1)
  • dying (3)
  • entospletinib (1)
  • fcr (5)
  • FDA (2)
  • FISH (8)
  • follicular lymphoma (13)
  • generic drugs (1)
  • health care reform (7)
  • holistic care (1)
  • hospice (3)
  • ibrutinib (18)
  • idelalisib (5)
  • immunotherapy (1)
  • lenalidamide (1)
  • lenalidomide (2)
  • lymphoma biology (3)
  • lymphoma treatment (10)
  • mantle cell lymphoma (1)
  • myc (1)
  • notch (4)
  • obinutuzumab (7)
  • ofatumumab (2)
  • off label drugs (2)
  • p53 (5)
  • personalized medicine (5)
  • PI3K (4)
  • R-CHOP (2)
  • Research Drugs (13)
  • rituximab (6)
  • scans (1)
  • sf3b1 (1)
  • stereotype (1)
  • supplements (1)
  • syk (1)
  • T cell therapy (3)
  • transplant (2)
  • trisomy 12 (1)
  • venetoclax (1)
  • videos (7)
  • watch and wait (2)
  • zydelig (1)

Popular Posts

  • 17p Deletion in CLL
    17p is the genomic alteration in CLL that triggers the greatest concern in most patients.  It can have a tremendous impact on CLL prognosi...
  • When to treat CLL
    The " watch and wait " mantra in CLL can be a test of wills unlike most other cancer experiences. Let's face it, sitting the...
  • Mutated vs. Unmutated CLL
    I was surprised to realize that I have not posted on the difference between “mutated” and “unmutated” CLL.   This is such a basic charac...
  • CLL Prognosis
    Many CLL patients identify themselves by their prognostic markers when writing in social media outlets.  "Diagnosis age 63, unmutated, ...
  • Monoclonal B Cell Lymphocytosis
    If you took blood samples from individuals on an annual basis and stuck them in the freezer for analysis sometime later, you would find that...
  • FCR: The Empire Strikes Back
    I'm not really a huge Star Wars guy, but the title seemed appropriate for the content.  For web savvy CLL patients FCR is a lot like the...
  • The Slow (Indolent) Lymphomas
    In my prior post " Understanding The Different Types of Lymphoma " I spent a bit of time explaining how there were three main cate...

Blog Archive

  • ▼  2017 (2)
    • ▼  April (1)
      • Research Plug!
    • ►  February (1)
  • ►  2016 (4)
    • ►  May (1)
    • ►  April (2)
    • ►  March (1)
  • ►  2015 (5)
    • ►  November (1)
    • ►  June (1)
    • ►  May (1)
    • ►  February (2)
  • ►  2014 (22)
    • ►  November (1)
    • ►  October (1)
    • ►  September (6)
    • ►  July (3)
    • ►  June (1)
    • ►  May (2)
    • ►  April (1)
    • ►  March (1)
    • ►  February (3)
    • ►  January (3)
  • ►  2013 (50)
    • ►  December (4)
    • ►  November (8)
    • ►  October (2)
    • ►  September (3)
    • ►  July (2)
    • ►  June (7)
    • ►  May (11)
    • ►  April (5)
    • ►  March (2)
    • ►  February (1)
    • ►  January (5)
  • ►  2012 (30)
    • ►  December (4)
    • ►  November (2)
    • ►  October (4)
    • ►  September (5)
    • ►  August (8)
    • ►  July (7)

Good Discussion Groups

  • Lymphomation
  • Lymphoma Forum
  • CLL Forum
  • Yahoo Group CLL/SLL
  • Gotcll
  • CLL Topics
  • CLL Canada

Educational Links

  • LLS CLL Book
  • LLS Lymphoma book
  • Good European Perspective on CLL
  • Genentech Follicular Lymphoma Page
  • Genentech DLBCL page
  • Genentech CLL Page

Subscribe To

Posts
Atom
Posts
All Comments
Atom
All Comments

Follow this blog

Posts
Atom
Posts
All Comments
Atom
All Comments

RSS feed

Posts
Atom
Posts
All Comments
Atom
All Comments
Powered by Blogger.